In a stem‐cell‐based model of CML, restoration of p53 activity slowed the progression of the disease and extended the survival of leukemic animals by inducing the apoptotic death of primitive leukemic cells (Velasco‐Hernandez et al, 2013). The gene discussed is TP53; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.